CLPH- 291

N/A

Report date: 2025/01/03 16:39:19

Base Information

Drug NameCLPH- 291
Drug Alias NameCLPH- 291
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWiskott-Aldrich SyndromeThrombastheniaBernard-Soulier Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellphire Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellphire Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsWiskott-Aldrich SyndromeThrombastheniaBernard-Soulier Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A